Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: Treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

Marcello Tiseo, Luca Boni, Francesca Ambrosio, Andrea Camerini, Maria Giuseppa Vitale, Editta Baldini, Saverio Cinieri, Francesca Zanelli, Efisio Defraia, Rodolfo Passalacqua, Lucio Crino, Claudio Dazzi, Carmelo Tibaldi, Gianni M. Turolla, Vito D'Alessandro, Nicoletta Zilembo, Ferdinando Riccardi, Andrea Ardizzoni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: Treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences